LAURA WEST: Open Payments
NPI 1376932830 · NEWBERN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$631 in 37 payments from 8 companies in 2025. Trend: 2023 $362 · 2024 $624 · 2025 $631
Food & beverage: $631
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $303 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $134 |
| ABBVIE INC. | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Lilly USA, LLC | 2 | $33 |
| Abbott Laboratories | 1 | $23 |
| Astellas Pharma US Inc | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: Ozempic, JARDIANCE, Wegovy, UBRELVY, CAPLYTA, MOUNJARO, QULIPTA, Veozah.
Industry payments across TN — which companies pay providers there.
